“After fifty years, billions of dollars of intensive marketing campaigns, and tens of billions of dollars of profits for pharmaceutical companies,” writes George Scialabba, “it is still far from clear that antidepressant drugs are any more effective than placebo. The only group of people who have demonstrably benefited from the widespread use of antidepressants are pharmaceutical executives and investors.”
There’s more—much more—in Scialabba’s forthcoming How to Be Depressed, excerpted in the current issue of n+1 magazine.
